Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$765K Buy
22,405
+289
+1% +$10.4K 0.56% 46
2024
Q3
$904K Buy
22,116
+61
+0.3% +$2.5K 0.69% 38
2024
Q2
$849K Sell
22,055
-1,192
-5% -$50.1K 0.71% 35
2024
Q1
$963K Sell
23,247
-339
-1% -$14K 0.89% 27
2023
Q4
$874K Buy
+23,586
New +$847K 0.79% 35
2023
Q2
$824K Buy
+23,115
New +$829K 0.79% 37

Other funds holding GSK

Northwest Bank & Trust's GSK Position: Q4 2024 in Review

Northwest Bank & Trust increased its GSK (GSK) stake by 1.3% in Q4 2024, buying an estimated $10.4K and bringing the position to 22,405 shares worth $765K. The position accounts for 0.56% of the portfolio, ranked #46.

Northwest Bank & Trust first reported a position in GSK in Q2 2023 and has held it in 6 quarters since. The position peaked at $963K in Q1 2024. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Northwest Bank & Trust held 22,405 shares of GSK worth $765K as of Q4 2024.
  • Northwest Bank & Trust bought 289 GSK shares in Q4 2024, an estimated $10.4K.
  • GSK made up 0.56% of Northwest Bank & Trust's portfolio in Q4 2024, its #46 holding.
  • Northwest Bank & Trust first reported a position in GSK in Q2 2023 and has held it in 6 quarters since.
  • Northwest Bank & Trust's GSK position peaked at $963K in Q1 2024.
  • 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.